Filing Details
- Accession Number:
- 0001437749-19-024835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-23 20:20:26
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2019-12-23 20:20:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365733 | Jr P Joseph Pellegrino | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-19 | 5 | $0.00 | 31,054 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-19 | 238 | $35.83 | 30,816 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-12-19 | 2,785 | $36.05 | 28,264 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-20 | 1,762 | $0.00 | 30,026 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Dividend Equivalent Rights | Disposition | 2019-12-19 | 5 | $0.00 | 5 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-12-20 | 14,706 | $0.00 | 14,706 | $35.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23 | No | 4 | M | Direct | ||
| 14,706 | 2019-12-20 | 2026-12-20 | No | 4 | A | Direct |
Footnotes
- Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
- These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
Billionaire Hedge Funds
